Standout Papers

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carc... 2012 2026 2016 2021 704
  1. Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection (2012)
    Chun‐Ying Wu, Yi–Ju Chen et al. JAMA
  2. Global burden of hepatitis B virus: current status, missed opportunities and a call for action (2023)
    Yao‐Chun Hsu, Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
  3. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions (2024)
    Lung‐Yi Mak, Ken Liu et al. Nature Reviews Gastroenterology & Hepatology

Immediate Impact

3 by Nobel laureates 6 from Science/Nature 69 standout
Sub-graph 1 of 20

Citing Papers

Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Microbial transmission in the social microbiome and host health and disease
2024 Standout
2 intermediate papers

Works of Yao‐Chun Hsu being referenced

Global burden of hepatitis B virus: current status, missed opportunities and a call for action
2023 Standout
Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice
2018

Author Peers

Author Last Decade Papers Cites
Yao‐Chun Hsu 2014 1813 859 118 3.5k
Christos Triantos 2060 2354 1049 147 3.7k
Sheng‐Shun Yang 1827 1803 641 143 3.1k
A. De Santis 1531 1540 1231 109 3.2k
D. R. Triger 2172 2349 1023 98 4.0k
Mirella Fraquelli 3941 3065 1448 163 6.4k
Giovanni Marasco 1149 922 947 150 3.2k
Joseph J. Larson 2193 1517 1392 103 3.8k
Hyung Joon Yim 2728 2972 1098 235 4.5k
Woo Jin Chung 934 864 594 108 2.3k
Antonio Colecchia 2916 2561 2007 158 5.7k

All Works

Loading papers...

Rankless by CCL
2026